Publication:
Comorbidity of Migraine and Epilepsy in Pediatrics: A Review

dc.contributor.authorJancic, Jasna (35423853400)
dc.contributor.authorDjuric, Vesna (19534167500)
dc.contributor.authorHencic, Boris (57195604277)
dc.contributor.authorvan den Anker, John N. (7006245836)
dc.contributor.authorSamardzic, Janko (23987984500)
dc.date.accessioned2025-06-12T16:06:06Z
dc.date.available2025-06-12T16:06:06Z
dc.date.issued2018
dc.description.abstractMigraine and epilepsy are classified as chronic paroxysmal neurologic disorders sharing many clinical features, as well as possible treatment options. This review highlights the similarities between migraine and epilepsy in pediatrics, focusing on epidemiologic, pathophysiological, genetic, clinical, and pharmacologic aspects. Despite the fact that several syndromes share symptoms of both migraine and epilepsy, further research is needed to clarify the pathophysiological and genetic basis of their comorbidity. Drugs used for prophylactic therapy of migraine and epilepsy have similar pharmacologic properties. The role of epileptic pharmacotherapy in the prophylaxis of migraine is assessed, including the use of conventional antiepileptic drugs, calcium channel blockers, and nonpharmacologic methods such as dietary therapy, supplements, and vagal nerve stimulation. Further randomized, controlled clinical trials assessing pharmacologic and nonpharmacologic methods for the treatment of both disorders are essential, in order to initiate new therapeutic approaches. © The Author(s) 2018.
dc.identifier.urihttps://doi.org/10.1177/0883073818788942
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85052576997&doi=10.1177%2f0883073818788942&partnerID=40&md5=74482abb8dfc9c0945244691d6e765b3
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/6115
dc.subjectchildren
dc.subjectcomorbidity
dc.subjectepilepsy
dc.subjectmigraine
dc.titleComorbidity of Migraine and Epilepsy in Pediatrics: A Review
dspace.entity.typePublication

Files